check_circleStudy Completed

Skin Mycoses

Bayer Identifier:

2008/01850

ClinicalTrials.gov Identifier:

NCT00722189

EudraCT Number:

Not Available

EU CT Number:

Not Available
Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of Mycoses

Trial purpose

An assessment of the efficacy and safety of Travogen cream and Travocort cream in the treatment of local skin mycoses

Key Participants Requirements

Sex

Both

Age

N/A
  • - Diagnosis of skin mycosis

  • - Allergies to study medication

Trial summary

Enrollment Goal
900
Trial Dates
July 2008 - February 2009
Phase
N/A
Could I Receive a placebo
N/A
Products
Isoconazole
Accepts Healthy Volunteer
No

Where to participate

StatusInstitutionLocation
Completed
Kashkin Clinical Research Mycological InstituteSt Petersburg, Russia

Primary Outcome

  • Efficacy of Travogen / Travocort in the treatment of skin mycoses / Travogen Cream and Travocort Cream will be prescribed by a physician
    date_rangeTime Frame:
    Baseline to end of study
    enhanced_encryption
    Safety Issue:
    No

Secondary Outcome

  • Patient satisfaction
    date_rangeTime Frame:
    Baseline to end of study
    enhanced_encryption
    Safety Issue:
    No

Trial design

Observational Study of the Efficacy, Safety and Tolerance of Travogen Cream (Isoconazole) and Travocort Cream (Isoconazole, Diflurcortolone) in the Treatment of Patients With Local Skin Mycosis of Various Etiology and Localization
Trial Type
Observational
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here and search for websynopsis results